FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

372917005: Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1211435017 Protein-tyrosine kinase inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
3520810019 Substance with protein-tyrosine kinase inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3559306016 Substance with protein-tyrosine kinase inhibitor mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module

96 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with protein-tyrosine kinase inhibitor mechanism of action Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Substance with protein-tyrosine kinase inhibitor mechanism of action Is a Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) false Inferred relationship Existential restriction modifier
Substance with protein-tyrosine kinase inhibitor mechanism of action Is a Substance with protein kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Substance with protein-tyrosine kinase inhibitor mechanism of action Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
cabozantinib Is a False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Carbozantinib Is a False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ibrutinib Is a False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Lenvatinib Is a False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Osimertinib Is a False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Trametinib Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabozantinib Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ibrutinib Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabozantinib 20mg capsules Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabozantinib 20mg capsules and Cabozantinib 80mg capsules Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabozantinib 80mg capsules Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ibrutinib 140mg capsules Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Lenvatinib 10mg capsules Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Lenvatinib 4mg capsules Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Trametinib 500micrograms tablets Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Mekinist 2mg tablets (Imported (United States)) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cometriq 20mg capsules (Swedish Orphan Biovitrum Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cometriq 80mg capsules (Swedish Orphan Biovitrum Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cometriq 20mg capsules and Cometriq 80mg capsules (Swedish Orphan Biovitrum Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Imbruvica 140mg capsules (Janssen-Cilag Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Lenvima 4mg capsules (Eisai Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Lenvima 10mg capsules (Eisai Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Mekinist 2mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Mekinist 0.5mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Osimertinib Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Osimertinib 40mg tablets Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (AstraZeneca UK Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Kisplyx 4mg capsules (Eisai Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Kisplyx 10mg capsules (Eisai Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabozantinib 20mg tablets Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabozantinib 40mg tablets Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabometyx 40mg tablets (Ipsen Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabozantinib 60mg tablets Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cabometyx 60mg tablets (Ipsen Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Alectinib Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Alectinib 150mg capsules Has active ingredient False Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Alecensa 150mg capsules (Roche Products Ltd) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Mekinist 2mg tablets (Originalis B.V.) Has active ingredient True Substance with protein-tyrosine kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier

Start Page 2 of 2

This concept is not in any reference sets

Back to Start